You are here

Articles

Imperial College, London: Scientists seek out cancer cells hiding from treatment

published: 24 January 2013

EMA- CHMP recommends the EU Commission grant a conditional marketing authorisation for 'Bosulif' (bosutinib)

published: 22 January 2013

ARIAD and the U.K. National Cancer Research Institute to Collaborate on SPIRIT 3 Clinical Study

published: 8 January 2013

Change in Grade Low Grade Side Effects in ph+CML cp patients after switching therapy from IM to NIL

published: 4 January 2013

Winning the battle against leukaemia: positive early results in clinical trial for DNA vaccine: 07 December 2012

published: 21 December 2012

How close are we to targeting the leukemia stem cell?

published: 19 December 2012

FDA NEWS RELEASE For Immediate Release: Dec. 14, 2012

published: 14 December 2012

Temple Scientists Target DNA Repair to Eradicate Leukemia Stem Cells

published: 14 December 2012

Ponatinib, research collaboration between the Knight Cancer Institute and ARIAD-

published: 3 December 2012

ASH 2012: CML Abstracts

published: 12 November 2012

CML: the good, the better, and the difficult choices: Jorge Cortes

published: 8 November 2012

Is Imatinib Still an Acceptable First-Line Treatment for CML in Chronic Phase?: John Goldman and David Marin

published: 27 October 2012

Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy

published: 27 October 2012

News Release Ariad Announces FDA Acceptance of NDA Filing for Ponatinib in CML and Ph+ALL

published: 24 October 2012

EPIC- tial open for enrollment: ponatinib vs imatinib in newly diagnosed CML

published: 24 October 2012

CML in pregnancy and childhood.

published: 15 October 2012

Ariad Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML October 1, 2012

published: 3 October 2012

Reduced-Intensity Conditioning (RIC) Vs Standard Conditioning pre: Allogeneic Haemopoietic Cell Transplantation in Acute Myeloid Leukaemia in 1st Complete Remission:Lancet Oncol. 2012 Sept 6

published: 25 September 2012

FDA Approves Bosutinib for Previously Treated CML- 5th September 2012

published: 25 September 2012

'Your Blood'- Media Planet Guardian Supplement 12th September 2012

published: 13 September 2012